#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13806	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2164	632.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1678	1678	T	770	T,C	721,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13806	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2164	632.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1412	1412	C	789	C,T	739,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3508	710.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1687	1687	A	845	A,G	798,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3508	710.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2321	2321	C	818	C	748	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3508	710.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2395	2395	A	778	A	719	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25032	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3508	710.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2947	2947	C	764	C,T	716,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	34448	blaTEM	861	861	100.0	blaTEM.l15.c17.ctg.1	1439	2370.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1834	folP	855	855	99.88	folP.l15.c4.ctg.1	1461	124.7	1	SNP	p	R229S	1	.	.	685	687	AGC	972	974	AGC	212;213;211	A;G;C	199;199;197	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5228	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3510	148.7	0	.	p	.	0	G95A	NONSYN	283	285	GGC	665	667	GCC	179;179;175	G,T;C,A;C	166,1;165,1;163	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5228	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3510	148.7	1	SNP	p	S91F	1	.	.	271	273	TTC	653	655	TTC	180;180;180	T;T;C	166;168;167	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1472	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1498	98.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	453	455	ACC	199;196;195	A;C;C	190;191;190	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1472	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1498	98.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	651	653	CAC	182;181;180	C;A;C	174;171;172	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1472	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1498	98.2	0	.	p	.	0	A127fs	FSHIFT	379	379	G	717	717	G	169	G	159	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	531	1472	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1498	98.2	1	SNP	p	G45D	0	.	.	133	135	GGC	471	473	GGC	208;209;210	G;G,A;C	202;202,1;204	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	898	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1142	78.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4680	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2971	156.8	0	.	p	.	0	S87N	NONSYN	259	261	AGT	586	588	AAT	183;183;183	A;A;T	168;169;167	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4680	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2971	156.8	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1477	1479	GTC	191;191;191	G;T;C	185;183;184	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4680	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2971	156.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1630	1632	GCA	170;170;171	G;C;A	157;155;156	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4680	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2971	156.8	1	SNP	p	D86N	0	.	.	256	258	GAC	583	585	GAC	189;188;186	G;A;C	178;174;169	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4680	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2971	156.8	1	SNP	p	S88P	0	.	.	262	264	TCC	589	591	TCC	183;184;186	T;C,A;C	167;168,1;169	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4102	parE	1986	1986	99.95	parE.l15.c17.ctg.1	2628	155.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1529	1531	GGC	209;208;207	G;G;C	197;195;195	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1223	1225	GCA	208;206;204	G;C,T;A	192;190,1;192	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1226	1228	ATC	203;196;197	A;T;C	191;182;186	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1238	1240	GTG	203;202;201	G;T;G	193;190;191	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1238	1240	GTG	203;202;201	G;T;G	193;190;191	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1742	1744	ACC	237;235;235	A;C;C	212;213;213	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1796	1798	GCG	207;210;206	G;C;G,T	183;169;170,1	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1796	1798	GCG	207;210;206	G;C;G,T	183;169;170,1	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1919	1921	GGT	171;169;168	G;G;T	161;158;152	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1928	1930	GGC	163;161;157	G;G;C	150;149;145	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4012	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2405	165.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1946	1948	CCG	133;137;145	C,G;C,G;G,C	99,1;106,1;109,1	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5494	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3248	168.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1735	1737	CCG	213;216;211	C;C;G	196;205;193	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2270	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1762	128.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	543	543	C	159	C	151	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	337	339	GAA	242;237;235	G,T;A;A	227,1;225;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	D121G	NONSYN	361	363	GAC	586	588	GGC	223;222;219	G;G;C	217;216;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	748	750	TCA	214;219;217	T;C;A	200;205;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	784	786	CAA	243;243;245	C;A,G;A	233;232,1;235	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	G189S	NONSYN	565	567	GGC	790	792	AGC	248;248;250	A;G,A;C	235;235,1;236	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	F215T	NONSYN	643	645	TTT	868	870	ACT	250;250;245	A;C;T	239;239;234	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	877	879	GTG	237;236;234	G;T;G,C	225;224;222,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	A242V	NONSYN	724	726	GCC	949	951	GTT	227;226;227	G;T;T	215;214;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	0	.	p	.	0	V293A	NONSYN	877	879	GTT	1102	1104	GCT	203;207;209	G;C;T	188;195;194	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2852	porB1b	1047	1047	98.47	porB1b.l15.c17.ctg.1	1412	198.8	1	SNP	p	G120K	1	.	.	358	360	AAG	583	585	AAG	223;221;222	A;A;G	218;216;216	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10310	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4882	210.8	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2041	2043	AAT	229;228;228	A;A;T	216;214;211	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1144	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1110	102.9	1	SNP	p	V57M	1	.	.	169	171	ATG	623	625	ATG	269;269;269	A;T;G	256;255;254	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	M177T	NONSYN	529	531	ATG	889	891	ACG	363;362;362	A;C,T;G	350;352,1;352	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	910	912	GAC	334;330;325	G;A;C	331;323;323	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	T190M	NONSYN	568	570	ACG	928	930	ATG	307;305;306	A;T;G	305;304;304	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	L194S	NONSYN	580	582	TTA	940	942	TCA	304;304;300	T;C;A	300;302;296	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	985	987	CAG	336;336;333	C;A;G,T	333;331;329,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1006	1008	CTT	323;321;321	C;T;T	321;319;320	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1027	1029	AGT	323;326;330	A;G;T	314;317;310	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1096	1098	CCG	380;385;390	C;C,G;G	363;367,1;372	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1198	1200	TCG	479;481;483	T;C;G	460;463;465	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1369	1371	AAA	292;287;281	A;A;A	281;275;270	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1372	1374	AAG	276;275;271	A;A;G	267;267;262	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1387	1389	CAC	241;242;241	C;A;C	237;233;236	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1426	1428	GAA	226;223;227	G;A;A	223;222;225	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1504	1506	ACG	175;175;175	A;C;G	173;175;172	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1555	1557	ATT	232;230;233	A;T;T	222;220;222	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1558	1560	AGT	233;232;231	A;G;T	222;220;220	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1597	1599	CTA	252;252;253	C;T;A	239;240;241	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1639	1641	AAT	163;164;167	A;A;T	158;158;162	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1708	1710	TCA	257;259;259	T;C,A;A	247;248,1;245	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1732	1734	ATG	281;282;282	A;T;G	271;273;272	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2026	2028	ACC	541;541;538	A;C;C	511;511;511	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9500	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2596	364.3	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2122	2124	GAA	524;524;530	G;A;A	499;499;504	.	Tetracycline resistance
